TMPRSS2, a novel host-directed drug target against SARS-CoV-2

Signal Transduct Target Ther. 2022 Jul 23;7(1):251. doi: 10.1038/s41392-022-01084-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Kommentar

MeSH terms

  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2*
  • Serine Endopeptidases / genetics

Substances

  • Serine Endopeptidases
  • TMPRSS2 protein, human